Get In TouchEN|中文 Group Our Company Why Partner with Us? Products & Services News & Resources Contact us CONTACT | Industrial R&D Project June 22, 2021 | Lincotek Medical, together with other Italian partners (Marrelli Health, Istituto Ortopedico Rizzoli, Politecnico di Milano and Politecnico di Bari), has been granted National Funding for a R&D project named CONTACT. The project aims to increase knowledge and innovation for the development of prosthetic implants, with a view to reducing time and costs in the production of the implant. The aim is to reduce the duration of surgery, improve post-operative care, and reduce the risk of multiple surgeries due to failures or infections. For Lincotek Medical, this is an opportunity to further study its electrochemical treatments, such as Calcium Phosphate coatings and 3DGrowth, possibly improving them with features like antibacterial proliferation capabilities. Project activities are focused on identifying the optimal combination of material, fabrication technology and surface modification to create patient-specific devices characterized by a reduced risk of post-operative complications. In particular, the devices will ideally: be customized on the individual patient; possess antibacterial or antibacterial proliferation capabilities; accelerate osseointegration; and be reabsorbable in a controlled manner when put in contact with the organic environment. Flexible manufacturing technologies such as additive manufacturing (AM) and superplastic forming (SPF) will ensure a high level of geometric complexity of the prosthesis, while the single-point incremental forming (SPIF) technique will be studied for comparison purposes. Titanium alloys (Ti), Magnesium alloys (Mg), and Chromium-Cobalt alloys (Cr-Co) will be taken into consideration for the fabrication. Osseointegration will be achieved and improved through different approaches: controlled modification of the surface roughness; chemical-physical modification through electrochemical treatments (Anodic Spark Deposition); sol-gel coatings; and calcium phosphate (CaP) coatings The modified surfaces will be characterized from a chemical, mechanical and physical point of view and the results will represent the basis for the study of the interaction of the implant with tissues, and of cell adhesion. The developed and treated materials will be tested and characterized through in-vivo and in-vitro tests to evaluate their cytocompatibility, genotoxicity and immunotoxicity. Additional Information Project financed by the National Operational Program Ricerca e Innovazione 2014-2020 and by Fondo di Sviluppo e Coesione Health Area; project code: ARS01_01205; CUP: B99C20000300005 Total cost: € €7,725.521.60 (grant funding €3,771.754.00) Cost for activities done in Lincotek Medical: € 235,922.56 (grant funding €106,521.50) Other partners of the project: Marrelli Health (lead partner), Istituto Ortopedico Rizzoli, Politecnico di Milano, Politecnico di Bari Start of activity: December 2020 Project duration: 30 months Share This Story, Choose Your Platform! Facebook Twitter Linkedin Related Posts Get in touch Select the company you would like to contact Italy - Trento Italy - Bologna Italy - Salerno U.S. - Fort Worth, Dayton, Portland, Logan U.S. - Memphis & Cincinnati China - Wuxi What would you like to contact us about? Product information Procurement query Research and development query Regulatory query Media enquiry Other (please write your query in the box below) I would like to be kept up to date with new initiatives, events, new products and new offers through newsletters, with traditional and/or automated contact methods. Privacy * The request for more information is free of charge and not binding, and sending this request constitutes the consent which is optional but necessary to provide you the service. Privacy Lincotek Group S.p.A. will disclose the Users’ Data to the product Strategic Business Units Surface Solution and Medical, since these latter are involved in the manufacturing and distribution of the product Additive. Legal Contact Code of ethics Model of organization, management, and control Newsletter Social WWW.LINCOTEKMEDICAL.COM – owned by Lincotek Rubbiano S.p.A. and used by Lincotek Trento S.p.A. - Via al Dos de la Roda 60, 38057 Pergine Valsugana, Trento (TN) Italy - Phone +39 0461 518901 – Fax +39 0461-518922 - VAT number, Tax Code and Economic Administrative Index No.: : IT 01305350223 - Economic Administrative Index Nr TN - 129060 - Paid-up Capital € 1.806.000,00 PEC: medical.TN@pec.lincotek.it | privacy@lincotek.com | Privacy Policy Web | Privacy Policy Cookie | Rights of Data Subjects | Cookie Settings